E-LIB Suche - Ergebnisse für: Abuasab, Tareq

1

Exploring the landscape of somatic ASXL2 mutations in myelo..:

Abuasab, Tareq ; Borthakur, Gautam ; Kanagal‐Shamanna, Rashmi...
American Journal of Hematology. 99 (2024) 7 - p. 1434-1436 , 2024

Link: https://doi.org/10.1002/..

2

Oral decitabine and cedazuridine plus venetoclax for older ..:

Bazinet, Alexandre ; Garcia-Manero, Guillermo ; Short, Nicholas...
The Lancet Haematology. 11 (2024) 4 - p. e276-e286 , 2024

Link: https://doi.org/10.1016/..

3

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Chien, Kelly ; Urrutia, Samuel ; LI, Ziyi...
HemaSphere. 7 (2023) S3 - p. e08202e6 , 2023

Link: https://doi.org/10.1097/..

4

Myeloid lineage switch in KMT2A-rearranged acute lymphoblas..:

Bataller, Alex ; Abuasab, Tareq ; McCall, David...
Haematologica. , 2023

Link: https://doi.org/10.3324/..

5

Outcomes of adult patients with relapsed/refractory CRLF2 r..:

Desikan, Sai Prasad ; Senapati, Jayastu ; Jabbour, Elias...
American Journal of Hematology. 98 (2023) 6 - p. , 2023

Link: https://doi.org/10.1002/..

6

AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazuridine) ..:

Abuasab, Tareq ; Alvarado, Yesid ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S237 , 2022

Link: https://doi.org/10.1016/..

7

Poster: AML-325 Prognostic Impact of RAS and C-KIT Mutation..:

Abuasab, Tareq ; Senapati, Jatastu ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S133 , 2022

Link: https://doi.org/10.1016/..

8

AML-387 Clinical Characteristics of Secondary Myeloid Neopl..:

Abuasab, Tareq ; Mohamed, Shehab F. ; Biostatistics, Hyunsoo Hwang...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S243 , 2022

Link: https://doi.org/10.1016/..

9

AML-325 Prognostic Impact of and Mutations (Single vs. Mult..:

Abuasab, Tareq ; Senapati, Jatastu ; Kadia, Tapan...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S235-S236 , 2022

Link: https://doi.org/10.1016/..

10

Poster: AML-328 Phase 2 Study of ASTX727 (Decitabine/Cedazu..:

Abuasab, Tareq ; Alvarado, Yesid ; Issa, Ghayas...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S125 , 2022

Link: https://doi.org/10.1016/..

11

Common kinase mutations do not impact optimal molecular res..:

Senapati, Jayastu ; Abuasab, Tareq ; Haddad, Fadi G....
American Journal of Hematology. 98 (2022) 3 - p. , 2022

Link: https://doi.org/10.1002/..

12

Poster: AML-387 Clinical Characteristics of Secondary Myelo..:

Abuasab, Tareq ; Mohamed, Shehab F. ; Biostatistics, Hyunsoo Hwang...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) - p. S134 , 2022

Link: https://doi.org/10.1016/..

13

Emerging Monoclonal Antibody Therapy for the Treatment of A..:

Abuasab, Tareq ; Rowe, Jacob ; Tvito, Ariella
Biologics: Targets and Therapy. 15 (2021) - p. 419-431 , 2021

Link: https://doi.org/10.2147/..

14

Myeloid lineage switch in KMT2A-rearranged acute lymphoblas..:

Bataller, Alex ; Abuasab, Tareq ; McCall, David...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10772528/. , 2023

Link: http://www.ncbi.nlm.nih...

15

P730: EVOLUTION OF IPSS-M RISK CATEGORIES IN PATIENTS WITH ..:

Chien, Kelly ; Urrutia, Samuel ; LI, Ziyi...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428879/. , 2023

Link: http://www.ncbi.nlm.nih...